Qui sommes-nous ?

Aqemia is a next-generation pharmaceutical company generating one of the fastest growing drug discovery pipelines in the world. Our mission is to develop groundbreaking drug candidates for scores of severe diseases. What sets us apart is our proprietary quantum mechanical and statistical algorithms that power generative artificial intelligence to design new drug candidates.
The velocity and precision of our technology platform allows us to scale drug discovery projects as technology projects.

We are proud of our team of over 40 highly motivated and spirited individuals standing at the intersection of Chemistry, Machine Learning, Physics, and Software Engineering.
We have raised $12 million from leading VCs so far.

Nos offres